These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 11603284

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Anti-inflammatory activity of parthenolide-depleted Feverfew (Tanacetum parthenium).
    Sur R, Martin K, Liebel F, Lyte P, Shapiro S, Southall M.
    Inflammopharmacology; 2009 Feb; 17(1):42-9. PubMed ID: 19112586
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Parthenolide inhibits the contractile responses of rat stomach fundus to fenfluramine and dextroamphetamine but not serotonin.
    Béjar E.
    J Ethnopharmacol; 1996 Jan; 50(1):1-12. PubMed ID: 8778501
    [Abstract] [Full Text] [Related]

  • 5. A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in-vitro.
    Groenewegen WA, Heptinstall S.
    J Pharm Pharmacol; 1990 Aug; 42(8):553-7. PubMed ID: 1981582
    [Abstract] [Full Text] [Related]

  • 6. Feverfew extracts and the sesquiterpene lactone parthenolide inhibit intercellular adhesion molecule-1 expression in human synovial fibroblasts.
    Piela-Smith TH, Liu X.
    Cell Immunol; 2001 May 01; 209(2):89-96. PubMed ID: 11446741
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Feverfew and vascular smooth muscle: extracts from fresh and dried plants show opposing pharmacological profiles, dependent upon sesquiterpene lactone content.
    Barsby RW, Salan U, Knight DW, Hoult JR.
    Planta Med; 1993 Feb 01; 59(1):20-5. PubMed ID: 8441776
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Patch test reactivity to feverfew-containing creams in feverfew-allergic patients.
    Paulsen E, Christensen LP, Fretté XC, Andersen KE.
    Contact Dermatitis; 2010 Sep 01; 63(3):146-50. PubMed ID: 20690937
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacological activity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.): assessment by inhibition of human polymorphonuclear leukocyte chemiluminescence in-vitro.
    Brown AM, Edwards CM, Davey MR, Power JB, Lowe KC.
    J Pharm Pharmacol; 1997 May 01; 49(5):558-61. PubMed ID: 9178194
    [Abstract] [Full Text] [Related]

  • 13. Parthenolide-depleted Feverfew (Tanacetum parthenium) protects skin from UV irradiation and external aggression.
    Martin K, Sur R, Liebel F, Tierney N, Lyte P, Garay M, Oddos T, Anthonavage M, Shapiro S, Southall M.
    Arch Dermatol Res; 2008 Feb 01; 300(2):69-80. PubMed ID: 18071724
    [Abstract] [Full Text] [Related]

  • 14. Contact allergy to parthenolide in Tanacetum parthenium (L.) Schulz-Bip. (feverfew, Asteraceae) and cross-reactions to related sesquiterpene lactone containing Compositae species.
    Hausen BM, Osmundsen PE.
    Acta Derm Venereol; 1983 Feb 01; 63(4):308-14. PubMed ID: 6195862
    [Abstract] [Full Text] [Related]

  • 15. Quantification of parthenolide in Tanacetum species by LC-UV/LC-MS and microscopic comparison of Mexican/US feverfew samples.
    Avula B, Navarrete A, Joshi VC, Khan IA.
    Pharmazie; 2006 Jul 01; 61(7):590-4. PubMed ID: 16889065
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antiproliferative activities of parthenolide and golden feverfew extract against three human cancer cell lines.
    Wu C, Chen F, Rushing JW, Wang X, Kim HJ, Huang G, Haley-Zitlin V, He G.
    J Med Food; 2006 Jul 01; 9(1):55-61. PubMed ID: 16579729
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The solution and solid state stability and excipient compatibility of parthenolide in feverfew.
    Jin P, Madieh S, Augsburger LL.
    AAPS PharmSciTech; 2007 Dec 14; 8(4):E105. PubMed ID: 18181526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.